These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 36896170)
21. Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy. Yan M; Li W; Wei R; Li S; Liu Y; Huang Y; Zhang Y; Lu Z; Lu Q J Transl Med; 2023 Jul; 21(1):490. PubMed ID: 37480090 [TBL] [Abstract][Full Text] [Related]
22. Identification of Lumican and Fibromodulin as Hub Genes Associated with Accumulation of Extracellular Matrix in Diabetic Nephropathy. Feng S; Gao Y; Yin D; Lv L; Wen Y; Li Z; Wang B; Wu M; Liu B Kidney Blood Press Res; 2021; 46(3):275-285. PubMed ID: 33887734 [TBL] [Abstract][Full Text] [Related]
23. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease. Chen X; Cao W; Zhuang Y; Chen S; Li X Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521 [TBL] [Abstract][Full Text] [Related]
24. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928 [TBL] [Abstract][Full Text] [Related]
25. Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p. Guo H; Yan Z; Hu Y; Huang X; Pan C Diabetes Metab Syndr Obes; 2021; 14():3077-3088. PubMed ID: 34262312 [TBL] [Abstract][Full Text] [Related]
26. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy. Chen S; Chen L; Jiang H Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy. Liu S; Wu W; Liao J; Tang F; Gao G; Peng J; Fu X; Zhan Y; Chen Z; Xu W; Zhao S Front Endocrinol (Lausanne); 2022; 13():895010. PubMed ID: 35865316 [TBL] [Abstract][Full Text] [Related]
28. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells. Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323 [TBL] [Abstract][Full Text] [Related]
29. Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy. Zhou G; Zhang X; Wang W; Zhang W; Wang H; Xin G Med Sci Monit; 2019 Mar; 25():1903-1916. PubMed ID: 30865617 [TBL] [Abstract][Full Text] [Related]
30. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277 [TBL] [Abstract][Full Text] [Related]
31. Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy. Lin J; Weng M; Zheng J; Nie K; Rao S; Zhuo Y; Wan J J Diabetes Investig; 2024 Jan; 15(1):87-105. PubMed ID: 37737517 [TBL] [Abstract][Full Text] [Related]
32. Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis. Han Y; Jin L; Wang L; Wei L; Tu C Kidney Blood Press Res; 2023; 48(1):522-534. PubMed ID: 37385224 [TBL] [Abstract][Full Text] [Related]
33. RNA-Seq Analysis of ceRNA-Related Networks in the Regulatory Metabolic Pathway of Mice with Diabetic Nephropathy Subjected to Empagliflozin Intervention. Wu T; Zhang Z; Huang H; Wu X Arch Esp Urol; 2023 Nov; 76(9):680-689. PubMed ID: 38053423 [TBL] [Abstract][Full Text] [Related]
34. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway. Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506 [TBL] [Abstract][Full Text] [Related]
35. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy. Wang J; Wang G; Liang Y; Zhou X J Diabetes Res; 2019; 2019():5204394. PubMed ID: 31218232 [TBL] [Abstract][Full Text] [Related]
36. Key Genes Associated with Pyroptosis in Gout and Construction of a miRNA-mRNA Regulatory Network. Bai B; Liu Y; Abudukerimu A; Tian T; Liang M; Li R; Sun Y Cells; 2022 Oct; 11(20):. PubMed ID: 36291136 [TBL] [Abstract][Full Text] [Related]
37. GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy. Li X; Liu J; Zeng M; Yang K; Zhang S; Liu Y; Yin X; Zhao C; Wang W; Xiao L Front Immunol; 2023; 14():1127612. PubMed ID: 37622120 [TBL] [Abstract][Full Text] [Related]
38. Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis. Tai Y; Zhao C; Gao J; Lan T; Tong H PeerJ; 2021; 9():e11910. PubMed ID: 34434654 [TBL] [Abstract][Full Text] [Related]
39. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis. Qu W; Han C; Li M; Zhang J; Li L Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of Differentially Expressed miRNAs and mRNAs Reveals That miR-181a-5p Plays a Key Role in Diabetic Dermal Fibroblasts. Liu P; Zhu Y; Li Q; Cheng B J Diabetes Res; 2020; 2020():4581954. PubMed ID: 33102604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]